[ Swiss Group for Clinical Cancer Research | Funding for translational cancer research ]

The Swiss Group for Clinical Cancer Research (SAKK) and Amgen Switzerland AG award this grant with the aim of furthering translational research in Switzerland that improve patients' lives. 
 
Who can apply: researchers or a research team independent of their nationality and age, who are currently working at a Swiss hospital or institution, are eligible to apply. 
 
Funding: CHF 50'000 should cover a relevant scientific part of the project.
 
Deadline: 30 September 2019 (every two years)
Decision: November 2019
 
Application: max. 3 pages and anonymous.
 
For further information and application, please have a look at the call webpage, call guidelines, online application form and info on past grantees.